Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
CVS Group plc (CVSGF)
Diss, GB
CVS Group plc, through its various subsidiaries, operates a comprehensive range of animal care services, including veterinary treatment, pet cremation, and online retail of pet supplies and pharmaceuticals. The company structures its diverse activities across four primary segments: its network of veterinary practices, diagnostic laboratories, crematoria, and its digital retail platform. It manages numerous animal veterinary clinics and offers complementary veterinary diagnostic support. Additionally, CVS Group provides pet cremation and clinical waste disposal solutions for veterinary establishments. Its online retail venture, Animed Direct, functions as both a dispensary and an e-commerce store, providing prescription and over-the-counter medications, pet food, and various other pet care essentials. The group further offers pet burial grounds, supplies veterinary instruments, and engages in property development. CVS Group plc maintains a significant footprint, owning 472 veterinary clinics, 3 laboratories, and 7 crematoria across the United Kingdom, the Netherlands, and the Republic of Ireland. Established in 1999, the company's main office is located in Diss, UK.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +0.00% | +0.30% | +2.03% | +7.61% | +2.03% | -4.89% | -30.64% | -16.83% | +20.36% | +20.36% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
-
Revenue growth Personal Products & Services: +6.6%+42.8% ★ Q4'25: +122.7% (vs Q4'23)
-
EPS growth Personal Products & Services: +19.6%+327.8% ★ Q4'25: -45.0% (vs Q4'23)
-
FCF margin FCF growth · Personal Products & Services: +11.7%+8.1% ★ Q4'25: +7.3% (vs Q4'23)
-
EBIT margin Personal Products & Services: +10.5%+7.4% Q4'25: +9.8% (vs Q4'23)
-
ROIC Personal Products & Services: +6.9%+6.4% Q4'25: +13.0% (vs Q4'23)
-
Share dilution Personal Products & Services: +0.0%+0.1% Q4'25: +0.0% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Personal Products & Services: 0.59×1.59× Q4'25: 1.32× (vs Q4'23)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Jun 2015 actual |
Jun 2016 actual |
Jun 2017 actual |
Jun 2018 actual |
Jun 2019 actual |
Jun 2020 actual |
Jun 2021 actual |
Jun 2022 actual |
Jun 2023 actual |
Jun 2024 actual |
Jun 2025 actual |
Jun 2026 8 Rev. Ana. 1 EPS Ana. |
Jun 2027 9 Rev. Ana. 1 EPS Ana. |
Jun 2028 3 Rev. Ana. 1 EPS Ana. |
Jun 2029 4 Rev. Ana. 1 EPS Ana. |
Jun 2030 5 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
167.30M
est: 262.22M (-36.2%)
|
218.10M
est: 289.34M (-24.6%)
|
271.80M
est: 351.31M (-22.6%)
|
327.30M
est: 430.23M (-23.9%)
|
406.50M
est: 517.35M (-21.4%)
|
427.80M
est: 512.50M (-16.5%)
|
510.10M
est: 693.95M (-26.5%)
|
554.20M
est: 677.34M (-18.2%)
|
588.90M
est: 769.45M (-23.5%)
|
647.30M
est: 662.63M (-2.3%)
|
924.17M
est: 673.61M (+37.2%)
|
699.60M
695.64M – 702.40M
+3.9% YoY
|
734.35M
723.14M – 739.50M
+5.0% YoY
|
770.49M
762.34M – 774.76M
+4.9% YoY
|
809.21M
800.66M – 813.70M
+5.0% YoY
|
816.59M
807.96M – 821.12M
+0.9% YoY
|
| EBITDA |
21.40M
est: 43.32M (-50.6%)
|
30.30M
est: 47.80M (-36.6%)
|
38.90M
est: 58.04M (-33.0%)
|
43.70M
est: 71.08M (-38.5%)
|
46.40M
est: 85.48M (-45.7%)
|
63.90M
est: 84.67M (-24.5%)
|
87.80M
est: 114.65M (-23.4%)
|
90.00M
est: 111.91M (-19.6%)
|
102.90M
est: 127.13M (-19.1%)
|
108.40M
est: 112.18M (-3.4%)
|
156.91M
est: 114.04M (+37.6%)
|
118.44M
117.77M – 118.92M
+3.9% YoY
|
124.33M
122.43M – 125.20M
+5.0% YoY
|
130.44M
129.07M – 131.17M
+4.9% YoY
|
137.00M
135.55M – 137.76M
+5.0% YoY
|
138.25M
136.79M – 139.02M
+0.9% YoY
|
| EBIT |
9.60M
est: 20.41M (-53.0%)
|
11.40M
est: 22.53M (-49.4%)
|
16.80M
est: 27.35M (-38.6%)
|
17.30M
est: 33.49M (-48.3%)
|
15.10M
est: 40.28M (-62.5%)
|
17.50M
est: 39.90M (-56.1%)
|
39.70M
est: 54.03M (-26.5%)
|
42.80M
est: 52.73M (-18.8%)
|
68.40M
est: 59.90M (+14.2%)
|
49.90M
est: 55.97M (-10.8%)
|
68.37M
est: 56.90M (+20.2%)
|
59.09M
58.76M – 59.33M
+3.9% YoY
|
62.03M
61.08M – 62.46M
+5.0% YoY
|
65.08M
64.39M – 65.44M
+4.9% YoY
|
68.35M
67.63M – 68.73M
+5.0% YoY
|
68.97M
68.25M – 69.36M
+0.9% YoY
|
| Net Income |
6.80M
est: 17.13M (-60.3%)
|
7.00M
est: 23.33M (-70.0%)
|
11.50M
est: 30.36M (-62.1%)
|
10.70M
est: 32.73M (-67.3%)
|
8.20M
est: 33.73M (-75.7%)
|
5.70M
est: 27.40M (-79.2%)
|
19.30M
est: 49.80M (-61.2%)
|
25.70M
est: 59.53M (-56.8%)
|
41.90M
est: 65.73M (-36.3%)
|
6.20M
est: 64.54M (-90.4%)
|
52.80M
est: 59.44M (-11.2%)
|
60.74M
59.90M – 61.17M
+2.2% YoY
|
66.77M
65.85M – 67.25M
+9.9% YoY
|
73.63M
72.62M – 74.16M
+10.3% YoY
|
80.48M
79.37M – 81.06M
+9.3% YoY
|
54.29M
53.54M – 54.68M
-32.5% YoY
|
| SGA |
60.80M
est: 91.14M (-33.3%)
|
80.37M
est: 100.57M (-20.1%)
|
107.30M
est: 122.11M (-12.1%)
|
133.90M
est: 149.54M (-10.5%)
|
153.30M
est: 179.83M (-14.8%)
|
151.60M
est: 178.14M (-14.9%)
|
181.80M
est: 241.21M (-24.6%)
|
196.30M
est: 235.44M (-16.6%)
|
189.70M
est: 267.45M (-29.1%)
|
227.10M
est: 217.19M (+4.6%)
|
235.90M
est: 220.79M (+6.8%)
|
229.30M
228.01M – 230.22M
+3.9% YoY
|
240.69M
237.02M – 242.38M
+5.0% YoY
|
252.54M
249.87M – 253.94M
+4.9% YoY
|
265.23M
262.43M – 266.70M
+5.0% YoY
|
267.65M
264.82M – 269.14M
+0.9% YoY
|
| EPS |
0.12
est: 0.24 (-49.8%)
|
0.12
est: 0.33 (-63.1%)
|
0.19
est: 0.42 (-55.2%)
|
0.16
est: 0.46 (-65.0%)
|
0.12
est: 0.47 (-74.5%)
|
0.08
est: 0.38 (-78.9%)
|
0.27
est: 0.70 (-61.2%)
|
0.36
est: 0.83 (-56.7%)
|
0.59
est: 0.92 (-35.7%)
|
0.09
est: 0.90 (-90.4%)
|
0.37
est: 0.83 (-55.3%)
|
0.85
0.83 – 0.85
+2.2% YoY
|
0.93
0.92 – 0.94
+9.9% YoY
|
1.03
1.01 – 1.03
+10.3% YoY
|
1.12
1.11 – 1.13
+9.3% YoY
|
0.76
0.75 – 0.76
-32.5% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-26 | B- | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-17 | B | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 2/5 | 2/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Richard William Mark Fairman | Chief Executive Officer & Director | 967.3K | male |
| Robin Jay Alfonso | Chief Financial Officer & Director | 662.7K | male |
| Paul Higgs | Chief Veterinary Officer & Director | 527.2K | male |
| Gordon Palmer | Head of IT | — | male |
| Helen Finney | Chief People Officer | — | female |
| James Cahill | MVB - Managing Director of CVS International | — | — |
| Charlotte Page | Group Financial Controller & Head of Investor Relations | — | — |
| Scott Morrison | Group General Counsel & Company Secretary | — | male |
| Claire Slater | Chief Operating Officer | — | female |
| Elizabeth McLennan-Green | Small Animal Veterinary Director | — | female |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for CVSGF
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
